Assessment of the BodyGuardian Remote Monitoring Platform in Elderly Healthy Subjects
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- Mayo Clinic
- 入组人数
- 20
- 试验地点
- 1
- 主要终点
- Number of subjects with successful data transfer at the end of 30 day monitoring period.
研究概览
简要总结
To adapt and refine the BodyGuardian remote health monitoring system to acquire ECG, Heart rate (HR), activity and breathing data, which will be integrated with weight, blood pressure and symptom data, in subjects in an independent living center, with wireless transmission of data to a central data analysis hub.
详细描述
The elderly are facing an increasing prevalence of chronic disease and rapidly escalating healthcare costs threatening independent living. Congestive heart failure (CHF) is a growing health epidemic and is associated with significant morbidity, mortality and cost. Mayo Clinic and Preventice have developed a non-invasive, minimally obtrusive, interactive remote monitoring platform. It enables on-body monitoring and integration of ECG, heart rate, breathing, and activity, with measures of weight and blood pressure. It is designed as a platform for physician directed patient self-management. This technology may be useful in monitoring CHF patients. Our overall objective is to adapt, refine, test and validate this technology in subjects in an independent living center, with wireless transmission of data to a central data analysis hub.
研究设计
- 研究类型
- Observational
- 观察模型
- Case Only
- 时间视角
- Prospective
入排标准
- 年龄范围
- 50 Years 至 —(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Resident at independent living facility
- •Adequate phone service
- •Healthy with life anticipated survival >than one year
排除标准
- •Skin reaction/allergies to adhesives
- •Have implantable pacemaker and/or defibrillator or have a bed partner with an implantable pacemaker
结局指标
主要结局
Number of subjects with successful data transfer at the end of 30 day monitoring period.
时间窗: approximately at the end of 30 day monitoring period
Data collected will be reviewed by engineering collaborators.
次要结局
未报告次要终点
研究者
Charles J. Bruce
Principal Investigator
Mayo Clinic
